The joint-development project combines KAKETSUKEN’s recombinant thrombin and fibrinogen know-how with the Teijin Group’s high-performance fiber and pharmaceutical technologies, with the aim of creating the world’s first recombinant fibrin sealant on electrospun fiber sheet. The product KTF-374 is bio-absorbable and need not be removed after use.

Teijin news release, June 20, 2014